A First-in-human Study of the Safety of an Immunosuppressive Antibody (IMP761) in Healthy Volunteers

NCT06637865 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

79

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: IMP761
DRUG: Placebo
OTHER: keyhole limpet haemocyanin (KLH)

Sponsor

Immutep S.A.S.